Nektar Therapeutics
NKTR
NKTR
203 hedge funds and large institutions have $3.69B invested in Nektar Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 84 increasing their positions, 59 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more capital invested
Capital invested by funds: $2.96B → $3.69B (+$733M)
3% more funds holding
Funds holding: 197 → 203 (+6)
0.06% more ownership
Funds ownership: 6.5% → 6.56% (+0.06%)
Holders
203
Holding in Top 10
8
Calls
$33.9M
Puts
$8.97M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$23.9M | |
| 3 | +$18.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$17.9M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$8.75M |
Top Sellers
| 1 | -$13M | |
| 2 | -$12.9M | |
| 3 | -$11.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$10.6M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$9.67M |